Theradaptive receives FDA breakthrough device designation for spinal fusion implant
Theradaptive has announced FDA breakthrough medical device designation for its Osteo-Adapt SP spinal fusion implant for use in transforaminal lumbar interbody procedures, according to a press release.The Osteo-Adapt SP implant is a regenerative implant indicated for patients with degenerative disc disease, spondylolisthesis or retrolisthesis who are undergoing transforaminal lumbar interbody